Design of a study of semaglutide in psychiatry, with Roger S. McIntyre, MD

Roger S. McIntyre, MD: GLP-1 agonists for psychiatry?

Although their clinical benefit for cardiometabolic, renal, hepatic, and obesity medicine may seem too good to be true, the GLP-1 and GIP receptor agonist incretin therapy drug classes are proving …

Read more

Roger S. McIntyre, MD: GLP-1 agonists for psychiatry?

Roger S. McIntyre, MD: GLP-1 agonists for psychiatry?

GLP-1/GIP receptor agonists, including semaglutide (Ozempic) and the investigational retatrutide, represent a seismic shift in cardiometabolic and comorbidity treatment. Over the past decade, the emerging drug class has been robustly …

Read more

Four Corners profiled Ange’s mum in 1996. Now she’s a mum trying to do things differently

Four Corners profiled Ange's mum in 1996. Now she's a mum trying to do things differently

In 1996, Ange McAuley was just 11 years old when ABC’s Four Corners profiled her family living on the outskirts of Brisbane. At the time, her mother was pregnant with …

Read more